BMO cuts Corpay stock price target to $440 from $450
BMO Capital Markets adjusted its outlook on Corpay (NYSE:CPAY) shares, reducing the price target to $440 from the previous $450, while retaining an Outperform rating on the stock. The company, ...
BMO raises Criteo stock price target to $60, maintains Outperform
BMO Capital Markets revised its price target for Criteo S.A. (NASDAQ:CRTO) shares, increasing it to $60 from the previous target of $48, while reaffirming an Outperform rating on the stock. The ...
Dayforce price target lowered to $83 from $90 at BMO Capital
BMO Capital lowered the firm’s price target on Dayforce (DAY) to $83 from $90 and keeps an Outperform rating on the shares. Following the ...
Investing24d
BMO Capital downgrades 4D Molecular Therapeutics stock to Market Perform, cites challenges
On Monday, BMO Capital Markets issued a downgrade for 4D Molecular Therapeutics (NASDAQ:FDMT) from Outperform to Market Perform, setting a price target of $15.00. The stock, currently trading at $ ...